You read Part 1.
You saw the pattern. Trump's WHO withdrawal. Infrastructure disruption. 90-day positioning window.
Now let's talk money.
Not theory. Not "opportunities to explore."
Specific plays. Revenue models. Action steps.
This is how you flip Trump's "global health crisis" into actual revenue.
I survived 25 years in Fortune 500 technology and marketing leadership.
International Harvester to Navistar collapse. AT&T breakup. Y2K infrastructure panic. 2008 financial crisis.
Here's what those decades taught me:
Consultants tell you what you want to hear. I tell you what you need to know.
Most advisors will hand you a 47-slide deck about "potential market opportunities" and "strategic considerations for post-WHO positioning."
You don't need potential. You need plays.
That's what this is.
Here's what you're getting:
Play #1: AI Disease Surveillance Platforms
Replace WHO's global networks. $10K-$50K enterprise subscriptions. 20-30% market growth spike.
Play #2: Pharma Supply Chain SaaS
Secure domestic logistics. $5K-$15K monthly + per-shipment fees. $5-10B addressable market.
Play #3: Bilateral Aid Management Tools
Track redirected WHO funding. $20K-$100K/year B2G subscriptions. Government contractor goldmine.
Play #4: Sovereignty Consulting
Navigate post-WHO landscapes. $20K-$50K monthly retainers. Crisis-to-revenue expertise.
Each play includes revenue models, 90-day roadmaps, and fractional CMO/CTO positioning.
No theory. Just execution.
When Trump pulled the U.S. out of the World Health Organization, $260-280 million in unpaid dues vanished overnight.
Critics panicked.
Smart operators asked: "Where does that money go instead?"
Answer: Domestic biodefense. Bilateral partnerships. U.S.-led health coalitions.
But here's the real opportunity:
WHO's budget hole is nothing compared to the infrastructure gaps Trump just created.
Every gap is worth billions to whoever fills it first.
The Gap:
U.S. surveillance systems depended on WHO's early-warning networks. Those networks just got cut. CDC, private labs, and hospital systems need alternatives immediately.
The Opportunity:
Build AI-driven disease tracking platforms that aggregate U.S. data sources independently. No WHO required.
Revenue Model:
SaaS subscriptions for hospitals, pharma firms, and government contractors.
Market Size:
Global health analytics projected at $100B+ by 2030. U.S.-centric surveillance tools could capture 20-30% growth spike post-WHO withdrawal.
Your 90-Day Roadmap:
Days 1-30: Build MVP using no-code tools (Bubble, Softr) integrating existing APIs
Days 31-60: Beta test with 3-5 regional hospitals
Days 61-90: Launch with sovereignty positioning
Fractional CTO Play:
As fractional CTO, I consult on MVP architecture, API integration strategy, and no-code deployment. $5K-$10K to validate technical feasibility. $20K-$50K for full MVP build and launch.
Why This Works:
You're not competing with WHO. You're replacing it. And you're doing it faster than bureaucrats can write RFPs.
The Gap:
WHO coordinated global pharma logistics and drug standards. Without that coordination, supply chains become vulnerable. Especially chains running through China-influenced networks.
The Opportunity:
Build blockchain-based pharma logistics platforms for U.S.-focused secure transport. Vetted drivers. Temperature-controlled tracking. Compliance without global bureaucracy.
Revenue Model:
Subscription + per-shipment fees.
Market Size:
U.S. pharma logistics market worth $90B annually. Trump's "America First" push could add $5-10B in domestic demand as firms decouple from China-influenced networks.
Your 90-Day Roadmap:
Days 1-30: Adapt existing short-haul vetting tech to pharma-specific requirements
Days 31-60: Partner with one mid-sized pharma manufacturer
Days 61-90: Scale via Trump policy tailwinds
Fractional CTO Play:
I specialize in turning regulatory disruption into technical advantage. Pharma supply chain apps need both marketing positioning (CMO) and blockchain implementation (CTO). That's exactly what fractional hybrid leadership delivers.
Why This Works:
UPS is pivoting to high-margin healthcare hauls. You're building the vetting platform they need. And you're doing it with sovereignty framing that resonates with Trump's base.
The Gap:
WHO loses $280M in U.S. funding. That money gets redirected to bilateral partnerships and U.S.-led coalitions. But there's no infrastructure to manage those new funding streams.
The Opportunity:
Build SaaS platforms for tracking bilateral health grants, outcomes, and partnerships. Governments and NGOs need tools for managing direct aid relationships.
Revenue Model:
High-ticket B2G (business-to-government) subscriptions.
Market Size:
Hundreds of millions in redirected U.S. health funding needs management infrastructure. Every dollar of aid requires reporting, tracking, and outcome measurement.
Your 90-Day Roadmap:
Days 1-30: Build grant tracking MVP
Days 31-60: Target State Department contractors
Days 61-90: Scale via government procurement channels
Fractional CMO Play:
Government contractors need marketing that speaks bureaucrat language while delivering technical credibility. That's my specialty. I position your SaaS as the inevitable replacement for WHO-dependent systems.
Why This Works:
Trump's team wants "true health and freedom" outside WHO. You're building the infrastructure that makes that possible. And you're getting paid by the same government that just defunded WHO.
The Gap:
Biotech firms, pharma companies, and health NGOs are scrambling to understand post-WHO operations. How do they maintain international partnerships? How do they navigate bilateral health agreements? Who replaces WHO's coordination role?
The Opportunity:
Position as the expert who's "seen this before" and offers crisis-to-revenue strategic consulting.
Revenue Model:
High-ticket fractional engagements.
Market Size:
Every major pharma company, biotech firm, and health NGO needs navigation strategy. That's thousands of potential clients with deep pockets.
Your 90-Day Roadmap:
Days 1-30: Build thought leadership positioning
Days 31-60: Land first consulting client
Days 61-90: Scale via referrals and content marketing
Fractional CMO/CTO Play:
This is my exact business model. I don't just advise on strategy (CMO). I help you build the technical infrastructure to execute (CTO). Most consultants give you theory. I give you implementation.
Why This Works:
You're not selling "consulting." You're selling pattern recognition from someone who survived AT&T breakup, International Harvester collapse, and Y2K panic. That credibility is worth $50K/month to executives betting their careers on post-WHO positioning.
Here's what these four plays have in common:
1. Speed Advantage
90-day window before this becomes obvious to everyone. Move now, dominate later.
2. Sovereignty Positioning
Frame every play as "America First health independence." That's not politics. That's market positioning.
3. Technical + Marketing Hybrid
You need both CMO strategy and CTO execution. Most operators only have one. That's why they lose.
You're reading this thinking: "These are good opportunities."
Wrong.
These aren't "opportunities." They're inevitable infrastructure replacements.
Trump didn't create optional market gaps. He created mandatory voids that MUST be filled.
The only question is: Do you fill them? Or does your competitor?
I'm not a newsletter creator who needs 100,000 subscribers.
I'm a fractional CMO/CTO who serves 4 clients maximum at $2K-$5K monthly retainers.
I don't want everyone. I want the right ones.
If you're an executive or board member looking at Trump's WHO withdrawal and seeing crisis, this isn't for you.
If you're seeing $10 billion in infrastructure gaps and asking "How do I capture that?", keep reading.
I just gave you four plays worth billions.
Here's what you don't have:
That's exactly what MAD 2.0 delivers.
Not 2,000-word newsletters that create decision paralysis.
Scannable mind maps that show: What's happening. Why it matters. What to do.
Your CEO doesn't read your 47-tab research deck. They need one visual.
MAD 2.0 gives them that.
Subscribe to MAD 2.0 Intelligence →
You'll get:
Stop Reading. Start Seeing.
— Charles K Davis
Fractional CMO/CTO
Get MAD Intel → Subscribe Now
P.S. Most consultants will tell you to "monitor the WHO situation and assess strategic options." That's how you end up competing instead of leading. I survived International Harvester's collapse, the AT&T breakup, and Y2K infrastructure panic by moving while others debated. There's a 90-day window. Use it or lose it.
P.P.S. If you're a C-suite executive at a biotech or pharma company looking for fractional CMO/CTO expertise to execute one of these plays, I have limited capacity. Book a call here. I work with 4 clients maximum. No tire-kickers. No hand-holders. Just pattern recognition that turns Trump's WHO exit into revenue.
